CLINICAL_TRIALS
trial_result
· 2025-02-03
Clinical Trial Update: FIND CAN Trial: "CF-172" [NA]
Summary
The FIND CAN Trial evaluating CF-172 by Biosense Webster has completed for persistent atrial fibrillation.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biosense Webster, Inc. | Conditions: Persistent Atrial Fibrillation | NA | Status: COMPLETED